IN BRIEF: Syncona to focus on realisations to return GBP250 million
Syncona Ltd - London-based investor in life science companies - Sets out results of its strategy review, proposing focus on realisations of mature private companies in its portfolio until it has been able to return up to GBP250 million to shareholders "in a timely manner". The returns, representing about 40% of the company's current market value, could take the form of a tender offer, share buyback, or special dividend, Syncona says. Read More